ClinicalTrials.Veeva

Menu

Contrast Ultrasound Perfusion Imaging in Peripheral Arterial Disease (PAD)

Oregon Health & Science University (OHSU) logo

Oregon Health & Science University (OHSU)

Status

Completed

Conditions

Peripheral Arterial Disease

Study type

Observational

Funder types

Other

Identifiers

NCT01377649
IRB00007524

Details and patient eligibility

About

Contrast ultrasound is a technique that can quantify blood flow in the tissues of the body by ultrasound detection of microbubble contrast agents that behave in the circulation similar to red blood cells. In this study, the investigators hypothesize that contrast ultrasound of blood flow in the leg (thigh and calf) at rest and during stress produced by medications that mimic exercise (vasodilator stress) can provide information on the location and severity of peripheral vascular disease (blockages of the blood vessels in the leg). The investigators will also determine whether symptom improvement after revascularization (procedures to open up or bypass the blockages) is directly related to the improvement in blood flow.

Enrollment

18 patients

Sex

All

Ages

19+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Known or suspected PAD
  2. Lower extremity angiography or MRA planned or performed within 6 months

Exclusion criteria

  1. Age <19 y.o.
  2. Pregnant or lactating females
  3. Hypersensitivity to ultrasound contrast agent, dipyridamole, or regadenoson
  4. Severe reactive airways disease
  5. Evidence right-to-left shunt (identified on screening echo)
  6. NYHA Class III or IV heart failure.
  7. Planned amputation
  8. Unstable coronary artery disease or severe aortic stenosis

Trial design

18 participants in 2 patient groups

Control
Description:
Age matched control subjects without PAD
Patients with PAD

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems